PersonFounderExecutive
Alex Aravanis
Alex Aravanis is the CEO and co-founder of Moonwalk Biosciences, a precision epigenetics company he launched in 2024 with $57 million and Broad Institute scientist Feng Zhang. An engineer-turned-physician with degrees from UC Berkeley and Stanford, he co-founded the cancer early-detection company GRAIL, later returned to Illumina as Chief Technology Officer, and now wants to rewrite the 'software of the genome' without cutting a single strand of DNA.
moonwalk biosciencesepigeneticsepigenetic editingprecision medicinegenomicssingle-cell methylation